A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1322-1325

  Sirot, D ^a   Recule, C ^b   Chaibi, E B ^c   Bret, L ^a   Croize, J ^b   Chanal Claris, C ^a   Labia, R ^c   Sirot, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Ctr Natl de la Rech Sci MNHN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; TIMENTIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0031009295     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1322     Document Type: Article

References (22)

1. Ambler, R. P., A. F. N. Coulson, J. M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272.
2. Brun, T., J. Péduzzi, M. M. Caniça, G. Paul, P. Névot, M. Barthélémy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microblol. Lett. 120:111-118.
3. Chanal, C., M. C. Poupart, D. Sirot, R. Labia, J. Sirot, and R. Cluzel. 1992. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 β-lactamase genes. Antimicrob. Agents Chemother. 36:1817-1820.
4. Chen, S. T., and R. C. Clowes. 1987. Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. J. Bacteriol. 169:913-916.
5. Delaire, M., R. Labia, J. P. Samama, and J. M. Masson. 1992. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 β-lactamase. J. Biol. Chem. 267:20600-20606.
6. Du Bois, S. K., M. S. Marriott, and S. G. B. Amyes. 1995. TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35:7-22.
7. Goussard, S., and P. Courvalin. 1991. Sequence of the genes blaT-1B and blaT-2. Gene 102:71-73.
8. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
9. Imtiaz, U., E. K. Manavathu, S. Mobashery, and S. A. Lerner. 1994. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 β-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Antimicrob. Agents Chemother. 38: 1134-1139.
10. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
11. Jelsch, C., F. Lenfant, J. M. Masson, and J. P. Samama. 1992. β-Lactamase TEM-1 of E. coli. Crystal structure determination at 2.5 A resolution. FEBS Lett. 299:135-142.
12. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
13. Labia, R., J. Andrillon, and F. Le Goffic. 1973. Computerized microacidimetric determination of β-lactamase Michaelis-Menten constants. FEBS Lett. 33:42-44.
14. Labia, R., A. Morand, K. Tiwari, J. S. Pitton, D. Sirot, and J. Sirot. 1988. Kinetic properties of two plasmid-mediated β-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins. J. Antimicrob. Chemother. 21:301-307.
15. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
16. Mabilat, C., and P. Courvalin. 1990. Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 34: 2210-2216.
17. Oliphant, A. R., and K. Struhl. 1989. An efficient method for generating proteins with enzymatic properties: application to β-lactamase. Proc. Natl. Acad. Sci. USA 86:9094-9098.
18. Petit, A., L. Maveyraud, F. Lenfant, J. P. Samama, R. Labia, and J. M. Masson. 1995. Multiple substitutions at position 104 of β-lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem. J. 305:33-40.
19. Sirot, D., C. Chanal, C. Henquell, R. Labia, J. Sirot, and R. Cluzel. 1994. Clinical isolates of Escherichia coli producing multiple TEM-mutants resistant to β-lactamase inhibitors. J. Antimicrob. Chemother. 33:1117-1126.
20. Sowek, J. A., B. Singer, S. Ohringer, M. F. Mally, T. J. Dougherty, J. Z. Gougoutas, and K. Bush. 1991. Substitution of lysine at position 104 or 240 of TEM β-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry 30:3179-3188.
21. Sutcliffe, G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
22. Zhou, X. Y., F. Bordon, D. Sirot, M. D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.